AAAAAA

   
Results: 1-10 |
Results: 10
No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study
Authors: Vleggaar, FP van Buuren, HR Henegouwen, GPV Hop, WCJ van Erpecum, KJ
Citation: Fp. Vleggaar et al., No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study, EUR J GASTR, 13(2), 2001, pp. 171-175
Extrahepatic portal vein thrombosis: aetiology and determinants of survival
Authors: Janssen, HLA Wijnhoud, A Haagsma, EB van Uum, SHM van Nieuwkerk, CMJ Adang, RP Chamuleau, RAFM van Hattum, J Vleggaar, FP Hansen, BE Rosendaal, FR van Hoek, B
Citation: Hla. Janssen et al., Extrahepatic portal vein thrombosis: aetiology and determinants of survival, GUT, 49(5), 2001, pp. 720-724
Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant
Authors: Vleggaar, FP van Buuren, HR Zondervan, PE ten Kate, FJW Hop, WCJ
Citation: Fp. Vleggaar et al., Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant, GUT, 49(2), 2001, pp. 276-281
Management of osteoporosis in primary biliary cirrhosis
Authors: Wolfhagen, FHJ van Buuren, HR Vleggaar, FP Schalm, SW
Citation: Fhj. Wolfhagen et al., Management of osteoporosis in primary biliary cirrhosis, BEST PR RES, 14(4), 2000, pp. 629-641
High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
Authors: van Buuren, HR van Hoogstraten, HJF Terkivatan, T Schalm, SW Vleggaar, FP
Citation: Hr. Van Buuren et al., High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis, J HEPATOL, 33(4), 2000, pp. 543-548
Cholestatic liver diseases: Slow progress in understanding and treating slowly progressive disorders
Authors: Vleggaar, FP Van Ooteghem, NAM Van Buuren, HR Henegouwen, GPV
Citation: Fp. Vleggaar et al., Cholestatic liver diseases: Slow progress in understanding and treating slowly progressive disorders, SC J GASTR, 35, 2000, pp. 86-92
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study
Authors: Janssen, HLA Meinardi, JR Vleggaar, FP van Uum, SHM Haagsma, EB van der Meer, FJM van Hattum, J Chamuleau, RAFM Adang, RP Vandenbroucke, JP van Hoek, B Rosendaal, FR
Citation: Hla. Janssen et al., Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study, BLOOD, 96(7), 2000, pp. 2364-2368
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: A randomized double-blind pilot study
Authors: van Hoogstraten, HJF Vleggaar, FP Boland, GJ van Steenbergen, W Griffioen, P Hop, WCJ van Hattum, J Henegouwen, GPV Schalm, SW van Buuren, HR
Citation: Hjf. Van Hoogstraten et al., Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: A randomized double-blind pilot study, AM J GASTRO, 95(8), 2000, pp. 2015-2022
Prevention and treatment of osteoporosis in primary biliary cirrhosis
Authors: Vleggaar, FP van Buuren, HR Wolfhagen, FHJ Schalm, SW Pols, HAP
Citation: Fp. Vleggaar et al., Prevention and treatment of osteoporosis in primary biliary cirrhosis, EUR J GASTR, 11(6), 1999, pp. 617-621
Progress and novel discoveries in biliary tract diseases
Authors: Vleggaar, FP van Berge-Henegouwen, GP
Citation: Fp. Vleggaar et Gp. Van Berge-henegouwen, Progress and novel discoveries in biliary tract diseases, EUR J GASTR, 11(1), 1999, pp. 47-50
Risultati: 1-10 |